Physicians' responses to computerized drug-drug interaction alerts for outpatients
暂无分享,去创建一个
Yu-Chuan Li | Chien-Yeh Hsu | Ying-Jui Chang | Min-Li Yeh | Po-Yen Wang | Chien-Yeh Hsu | Y. Li | Y. Chang | Min-Li Yeh | Po-Yen Wang
[1] H. Tey,et al. Drug interactions in dermatological practice , 2008, Clinical and experimental dermatology.
[2] Mei-Shu Lin,et al. The Potential Drug-drug Interactions in an Ambulatory Prescription Data with Hypertensive Diagnosis in Taiwan(Hypertension, Clinical 8 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2005 .
[3] M. Jann,et al. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. , 2000, The Journal of clinical psychiatry.
[4] J. Deligne,et al. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999 , 2003, European Journal of Clinical Pharmacology.
[5] N. Laird,et al. Incidence of adverse drug events and potential adverse drug events , 1995 .
[6] K W Davidson,et al. Reduction of adverse drug reactions by computerized drug interaction screening. , 1987, The Journal of family practice.
[7] L. Kohn,et al. To Err Is Human : Building a Safer Health System , 2007 .
[8] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[9] D. Bates,et al. Improving safety with information technology. , 2003, The New England journal of medicine.
[10] A. Avery,et al. GPs' views on computerized drug interaction alerts: questionnaire survey , 2002, Journal of clinical pharmacy and therapeutics.
[11] David W Bates,et al. CPOE and clinical decision support in hospitals: getting the benefits: comment on "Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction". , 2010, Archives of internal medicine.
[12] O. Olesen,et al. Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism. , 2000, Journal of clinical psychopharmacology.
[13] Roger B. Davis,et al. Overrides of medication alerts in ambulatory care. , 2009, Archives of internal medicine.
[14] J. Hernández,et al. Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.
[15] Marc Berg,et al. Overriding of drug safety alerts in computerized physician order entry. , 2006, Journal of the American Medical Informatics Association : JAMIA.
[16] George Hripcsak,et al. Detecting adverse events for patient safety research: a review of current methodologies , 2003, J. Biomed. Informatics.
[17] Joan S. Ash,et al. Research Paper: Emotional Aspects of Computer-based Provider Order Entry: A Qualitative Study , 2005, J. Am. Medical Informatics Assoc..
[18] Barbara Simon,et al. Exposure to Automated Drug Alerts Over Time: Effects On Clinicians’ Knowledge And Perceptions , 2006, Medical care.
[19] D. Tatro. Drug Interaction Facts , 1990 .
[20] P Impicciatore,et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. , 2001, British journal of clinical pharmacology.
[21] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .
[22] Julie M. Fiskio,et al. Research Paper: Characteristics and Consequences of Drug Allergy Alert Overrides in a Computerized Physician Order Entry System , 2004, J. Am. Medical Informatics Assoc..
[23] Sandra L Kane-Gill,et al. A critical evaluation of clinical decision support for the detection of drug–drug interactions , 2011, Expert opinion on drug safety.
[24] P. Glassman,et al. Improving Recognition of Drug Interactions: Benefits and Barriers to Using Automated Drug Alerts , 2002, Medical care.
[25] Yu-Chuan Li,et al. The use of a CPOE log for the analysis of physicians' behavior when responding to drug-duplication reminders , 2008, Int. J. Medical Informatics.
[26] Chien-Yeh Hsu,et al. Potential drug interactions in dermatologic outpatient prescriptions—experience from nationwide population-based study in Taiwan , 2011 .
[27] Donna C. Dare,et al. Reasons provided by prescribers when overriding drug-drug interaction alerts. , 2007, The American journal of managed care.
[28] R. Beurskens,et al. Elevated plasma levels of clozapine after concomitant use of fluvoxamine , 1999, Pharmacy World and Science.
[29] Roger B. Davis,et al. Physicians' decisions to override computerized drug alerts in primary care. , 2003, Archives of internal medicine.